These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1288 related items for PubMed ID: 19538904
1. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program. Lange-Asschenfeldt C, Grohmann R, Lange-Asschenfeldt B, Engel RR, Rüther E, Cordes J. J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904 [Abstract] [Full Text] [Related]
2. Cardiac adverse effects associated with psychotropic drugs. Schmid C, Grohmann R, Engel RR, Rüther E, Kropp S. Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S65-9. PubMed ID: 15052516 [Abstract] [Full Text] [Related]
3. Galactorrhea due to psychotropic drugs. Kropp S, Ziegenbein M, Grohmann R, Engel RR, Degner D. Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S84-8. PubMed ID: 15052519 [Abstract] [Full Text] [Related]
6. Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project. Stübner S, Padberg F, Grohmann R, Hampel H, Hollweg M, Hippius H, Möller HJ, Rüther E. J Clin Psychiatry; 2000 Aug; 61(8):569-74. PubMed ID: 10982199 [Abstract] [Full Text] [Related]
7. Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study. Grohmann R, Engel RR, Geissler KH, Rüther E. Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S27-38. PubMed ID: 15052512 [Abstract] [Full Text] [Related]
8. The AMSP drug safety program: methods and global results. Grohmann R, Engel RR, Rüther E, Hippius H. Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S4-11. PubMed ID: 15052509 [Abstract] [Full Text] [Related]
9. Severe and uncommon involuntary movement disorders due to psychotropic drugs. Stübner S, Rustenbeck E, Grohmann R, Wagner G, Engel R, Neundörfer G, Möller HJ, Hippius H, Rüther E. Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S54-64. PubMed ID: 15052515 [Abstract] [Full Text] [Related]
10. Adverse psychic reactions to psychotropic drugs--a report from the AMUP study. Grohmann R, Ströbel C, Rüther E, Dirschedl P, Helmchen H, Hippius H, Müller-Oerlinghausen B, Schmidt LG, Wolf B. Pharmacopsychiatry; 1993 May; 26(3):84-93. PubMed ID: 8415899 [Abstract] [Full Text] [Related]
11. Cutaneous adverse drug reactions to psychotropic drugs and their risk factors - a case-control study. Greil W, Zhang X, Stassen H, Grohmann R, Bridler R, Hasler G, Toto S, Bleich S, Kasper S. Eur Neuropsychopharmacol; 2019 Jan; 29(1):111-121. PubMed ID: 30424913 [Abstract] [Full Text] [Related]
12. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups. Curran S, Turner D, Musa S, Wattis J. Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576 [Abstract] [Full Text] [Related]
13. Anticholinergic activity of commonly prescribed medications and neuropsychiatric adverse events in older people. Nishtala PS, Fois RA, McLachlan AJ, Bell JS, Kelly PJ, Chen TF. J Clin Pharmacol; 2009 Oct; 49(10):1176-84. PubMed ID: 19783711 [Abstract] [Full Text] [Related]
14. [Pharmacovigilance as new direction of research]. Gaszner G, Makkos Z, Gaszner P. Neuropsychopharmacol Hung; 2005 Dec; 7(4):194-8. PubMed ID: 16496484 [Abstract] [Full Text] [Related]
15. [Cutaneous side effects due to psychiatric drugs]. Rebok F, Pérez Roldán ML, Daray FM. Vertex; 2008 Dec; 19(82):348-56. PubMed ID: 19424517 [Abstract] [Full Text] [Related]